Northwell Health partnered with Stacker to explore how a new Pap smear alternative may help prevent deaths from cervical ...

Of the scores of day-one executive orders (EOs) issued by President Trump, the order rescinding a Biden administration executive order on ...

The drug received accelerated approval in October 2017 as monotherapy for adults with MCL who have received at least one ...

Approval was based on results from multiple studies, which demonstrated a slowing of cognitive decline in patients with ...

The Japanese and American based pharma companies announced a win for their Alzheimer’s treatment, which has faced some negative backlash over the last year.

The FDA approves a new maintenance dosing regimen for lecanemab (Leqembi; Eisai) in patients with early-stage Alzheimer ...

The regulatory agency will review MSD’s new drug application (NDA) for Welireg under a Priority Review, with a Prescription ...

The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner Biogen's Alzheimer's drug Leqembi, the companies said on Monday. The drug received standard ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

(HealthDay News) — The US Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at ...

Following an extensive scientific review, the US Food and Drug Administration has authorized the marketing of 20 ZYN nicotine pouch products.

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...